GW274150   Click here for help

GtoPdb Ligand ID: 9849

Synonyms: [2-[(1-iminoethyl) amino]ethyl]-L-homocysteine | GW-274150
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: GW274150 is a selective inducible nitric oxide synthase (iNOS) inhibitor that is active in vitro and in vivo [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 127
Molecular weight 219.1
XLogP -2.41
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=NCCSCCC(C(=O)O)N)N
Isomeric SMILES CC(=NCCSCC[C@@H](C(=O)O)N)N
InChI InChI=1S/C8H17N3O2S/c1-6(9)11-3-5-14-4-2-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1
InChI Key MOLOJNHYNHBPCW-ZETCQYMHSA-N
No information available.
Summary of Clinical Use Click here for help
GW274150 has completed Phase 2 clinical trial in RA patients (NCT00370435 and NCT00379990) [9], and has also been evaluated as an anti-migraine therapy [7] (Phase 2- but showed no efficacy in this indication [8]), and for anti-asthmatic efficacy (Phase 1) [6].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00370435 Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA) Phase 2 Interventional GlaxoSmithKline
NCT00379990 A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. Phase 2 Interventional GlaxoSmithKline